Implantable Drug Delivery Devices Market (Drug Infusion Pumps, Drug Delivery Devices, Bio-Absorbable Stents, Coronary Drug Eluting Stents, Brachytherapy Seeds, Contraceptive Drug Delivery Implants and Others) for Oncology, Contraception, Cardiovascular, Ophthalmology, Inflammatory Conditions, Diabetes and Other End-users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global implantable drug delivery devices market will reach around USD 17.5 billion by end of 2021, growing at a CAGR of around 7.1% between 2016 and 2021.

31-Aug-2016 | Number of pages: 110 | Report Code: ZMR-120 | Report Format : | Status : Published

Abstract

The report covers detailed analysis and forecast for the implantable drug delivery devices market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD billion).  The study includes a comprehensive view of the market with the review of market drivers, restraint, and opportunities. It also offers the level of impact of drivers and restraints on the implantable drug delivery devices market between 2015 and 2021.

The study included a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porter’s Five Forces model to analyze the different factors affecting the growth of the implantable drug delivery devices market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by product, end-user, and region.

The report includes detailed segmentation of implantable drug delivery devices market based on product, end-user, and region. Implantable drugs infusion pumps are the key product in the implantable drug delivery devices market. On the basis of end-user segment, the market can be classified into Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others end-users. Major regional segment analyzed in this report include Asia Pacific, North America, Europe, Latin America and the Middle East & Africa with its further bifurcation into major countries including China, Japan, India, U.S. Germany, France, UK, and Brazil.

The report provides detailed competitive outlook including market share and company profiles of the key players operating in the global market. Some of the key participants in the report include Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.

This report segments the global implantable drug delivery devices market as follows:

Global Implantable Drug Delivery Devices Market: Product Segment Analysis

  • Drug Infusion Pumps
  • Drug Delivery Devices
  • Bio-Absorbable Stents
  • Coronary Drug Eluting Stents
  • Brachytherapy Seeds
  • Contraceptive Drug Delivery Implants
  • Others

Global Implantable Drug Delivery Devices Market: End-user Segment Analysis

  • Oncology
  • Contraception
  • Cardiovascular
  • Ophthalmology
  • Inflammatory Conditions
  • Diabetes
  • Others

Global Implantable Drug Delivery Devices Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Contrast Injector Market by Product (Injector Systems, Consumables & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Aug-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2086 | Report Format:

The report covers forecast and analysis for the contrast Injector market on a global and regional level. The study provides historic data from 2014 along with a forecast from 2017 to 2022 based on revenue (USD Million). The study includes drivers and restraints for the contrast Injector market alo...Read More

Bioprocessing Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2058 | Report Format:

Global Bioprocessing Systems Market: Overview For the manufacturing of the biologics there is a requirement of the complicated process and thus the manufacturers prefer outsourcing it. Bioprocessing is the process which helps in the manufacturing of the bio-based products which includes fatty ac...Read More

Cartilage Repair/Cartilage Regeneration Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2042 | Report Format:

Global Cartilage Repair/Cartilage Regeneration Market: Overview Cartilage is considered as a flexible and soft elastic tissue; it has rubber kind of padding that covers and guards the ends of our long bones near the joints; it is a structural part of the ear, the intervertebral discs, the bronch...Read More

Portable Bioprocessing Bioreactors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2015 | Report Format:

Global Portable Bioprocessing Bioreactors Market: Overview The portable bioprocessing bioreactor is a device that is used for simulating a biochemical environment that is natural that helps in the proper growth of the tissues and the cells in the cell and microbial culture. If the parameters suc...Read More

Obesity Surgery Devices Market by Surgery Procedure (Gastric Bypass Surgery, Sleeve Gastrectomy Surgery, Gastric Banding Surgery and Others) and By Devices (Adjustable Gastric Bands, Intragastric Balloons, Clip Appliers, Surgical Staples, Trocars and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Aug-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2010 | Report Format:

The report covers forecast and analysis for the obesity surgery devices market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the obesity surgery devices ma...Read More

Choose License Type:
Latest Published Reports

View All Published Reports